Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany

Annual Meeting Archive


Voting Results 2016
Presence and voting resultspdf (43 kb)
Chairman´s report at the Annual General Meeting 2016 (Printversion)
Report of the Chairman of the Executive Board Karl-Ludwig Kleypdf (1.4 MB)  
News Release
Merck KGaA, Darmstadt, Germany, Annual General Meeting 2016: CEO Handover After Ten Successful Years
Documents to be made available
Agenda incl. proposal for the appropriation of net retained profitEnglish            
German
Annual Report of Merck KGaA, Darmstadt, Germany, for fiscal 2015 incl. the consolidated financial statements, combined management report and report of the Supervisory BoardEnglish
German
Single entity financial statements of Merck KGaA, Darmstadt, Germany, for fiscal 2015 incl. combined management report and report of the Supervisory BoardEnglish
German
Additional Information
Explanation of shareholder rightspdf (89 kb)  
Information on participation – Exercise of proxy voting

pdf (86 kb)  

Articles of Association of Merck KGaA, Darmstadt, Germany

pdf (296 kb)  

Voting Results 2015
Presence and voting results (German language)pdf (475 kb)
Chairman´s report at the Annual General Meeting 2015 (Printversion)
Report of the Chairman of the Executive Board Karl-Ludwig Kleypdf (1.2 MB)  
Press Release
Merck KGaA, Darmstadt, Germany, Proposes Dividend Increase to Shareholders After a Year of Key Strategic Moves – Foundation Set for Further Organic Growth
Documents to be made available
Agenda incl. proposal for the appropriation of net retained profitEnglish
German
Annual Report of Merck KGaA, Darmstadt, Germany for fiscal 2014 incl. the consolidated financial statements, Group management report and report of the Supervisory BoardEnglish
German
Single entity financial statements of Merck KGaA, Darmstadt, Germany for fiscal 2014 incl. management report and report of the Supervisory BoardEnglish
German
Documents in connection with agenda item 7 (Resolution on the approval of five control and profit and loss transfer agreements)
CompanyContract
(German only)
ReportAnnual Financial Statements
Merck KGaA,
Darmstadt, Germany


2013 (English)
2013 (German)
2012 (English)
2012 (German)
2011 (English)
2011 (German)
Merck 12. Allgemeine Beteiligungs-GmbH,
Darmstadt, Germany
 pdf (2.5 MB)

English

German

2014 (German only)  
2013 (German only)  
2012 (German only)
Merck 16. Allgemeine Beteiligungs-GmbH,
Darmstadt, Germany
 pdf (2.5 MB)English
German
2014 (German only)
Merck 17. Allgemeine Beteiligungs-GmbH,
Darmstadt, Germany
 pdf (2.5 MB)English
German
2014 (German only)
Merck 18. Allgemeine Beteiligungs-GmbH,
Darmstadt, Germany
 pdf (2.5 MB)English
German
2014 (German only)
Merck 19. Allgemeine Beteiligungs-GmbH,
Darmstadt, Germany
 pdf (2.5 MB)English
German
2014 (German only)
Voting Results 2014
Presence and voting results (German language)pdf (181 kb)
Chairman´s report at the Annual General Meeting 2014 (Printversion)
 Report of the Chairman of the Executive Board Karl-Ludwig Kleypdf (1.0 MB)
Documents
01.Agenda incl. proposal for the appropriation of net retained profitpdf (198 kb)
02.Annual Report of Merck KGaA, Darmstadt, Germany, for fiscal 2013 incl. the consolidated financial statements, Group management report and report of the Supervisory Boardpdf (5.1 MB)
03.Single entity financial statements of Merck KGaA, Darmstadt, Germany, for fiscal 2013 incl. management report and report of the Supervisory Boardpdf (3.0 MB)
04.Information on Supervisory Board candidates (appendix 1 to the agenda) (agenda item 7)pdf (241 kb)
05.Statement on the independence of Supervisory Board candidates (agenda item 7)pdf (382 kb)
06.Report of the Executive Board to the Annual General Meeting in accordance with Sections 278 (3), 203 (2) sentence 2 AktG in conjunction with Section 186 (4) sentence 2 German Stock Corporation Act regarding Agenda Item 9 (German language)pdf (1.7 MB)
07.Report of the Executive Board to the Annual General Meeting in accordance with Sections 278 (3), 221 (4) sentence 2 AktG in conjunction with Section 186 (4) sentence 2 German Stock Corporation Act regarding Agenda Item 10 (German language)pdf (4.2 MB)
Additional Information
 Explanation of shareholder rightspdf (370 kb)
Information on participation – Exercise of proxy voting

pdf (376 kb)

Articles of Association of Merck KGaA, Darmstadt, Germany

pdf (296 kb)


Information on Agenda Item 7Documents
Short CV Dr. Wolfgang Büchelepdf (268 kb)
Short CV Michaela Freifrau von Glenckpdf (255 kb)
Short CV Albrecht Merckpdf (302 kb)
Short CV Prof. Dr. Helga Rübsamen-Schaeffpdf (22 kb)
Short CV Prof. Dr. Gregor Schulzpdf (85 kb)
Short CV Prof. Dr. Theo Siegertpdf (271 kb)
Information on Supervisory Board candidates (appendix 1 to the agenda)pdf (241 kb)
Statement on the independence of Supervisory Board candidatespdf (382 kb)
Voting Results 2013
Presence and voting results (German language)pdf (335 kb)
Chairman´s report at the Annual General Meeting 2013 (Printversion)
 Report of the Chairman of the Executive Board Karl-Ludwig Kleypdf (1.3 MB)
Documents
01.Agenda incl. proposal for the appropriation of net retained profitpdf (317 kb)
02.Annual Report of Merck KGaA, Darmstadt, Germany, for fiscal 2012 incl. the consolidated financial statements, Group management report and report of the Supervisory Boardpdf (5.3 MB)
03.Single entity financial statements of Merck KGaA, Darmstadt, Germany, for fiscal 2012 incl. management report and report of the Supervisory Boardpdf (3.2 MB)
04.Information on Supervisory Board candidates (appendix 1 to the agenda) (agenda item 10)pdf (244 kb)
05.Statement on the independence of Supervisory Board candidates (agenda item 10)pdf (2.5 MB)
06.Report of the Executive Board in accordance with Sections 278 (3), 203 (2) sentence 2 in conjunction with Section 186 (4) sentence 2 German Stock Corporation Act regarding agenda item 11 (German language)pdf (1.2 MB)
Additional Information
 Explanation of shareholder rightspdf (286 kb)
Information on participation – Exercise of proxy voting

pdf (282 kb)


Information on Agenda Item 7


Documents to be made available pursuant Sections 293f and 295 (1) Sentence 2 AktG
      


CompanyAmendment AgreementOriginal AgreementReportAnnual Financial Statements
Merck KGaA, Darmstadt, Germany,    2012 pdf (3.2 MB)
2011 pdf (3.7 MB)
2010 pdf (3.0 MB)
Merck Export GmbHpdf (508 kb)pdf (766 kb)pdf (1.3 MB)2012 pdf (646 kb)
2011 pdf (630 kb)
2010 pdf (636 kb)
Merck Shared Services Europe GmbHpdf (514 kb)pdf (831 kb)pdf (1.3 MB)2012 pdf (588 kb)
2011 pdf (760 kb)
2010 pdf (753 kb)
Merck Consumer Health Care Holding GmbHpdf (513 kb)pdf (822 kb)pdf (510 kb)2012 pdf (3.5 MB)
2011 pdf (3.3 MB)
2010 pdf (3.6 MB)
Chemische Fabrik Lehrte Dr. Andreas Kossel GmbHpdf (510 kb)pdf (828 kb)pdf (1.3 MB)2012 pdf (905 kb)
2011 pdf (1.2 MB)
2010 pdf (1.2 MB)
2009 pdf (1.4 MB)
Chemitra GmbHpdf (504 kb)pdf (653 kb)pdf (1.3 MB)2012 pdf (2.3 MB)
2011 pdf (3.3 MB)
2010 pdf (3.3 MB)
Merck Versicherungsvermittlung GmbHpdf (519 kb)pdf (682 kb)pdf (1.3 MB)2012 pdf (2.6 MB)
2011 pdf (3.8 MB)
2010 pdf (3.8 MB)
2009 pdf (631 kb)
Merck Verwaltungsgesellschaft mbHpdf (524 kb)pdf (638 kb)pdf (1.3 MB)2012 pdf (481 kb)
2011 pdf (2.6 MB)
2010 pdf (2.6 MB)
Voting Results 2012
Presence and voting results (German language)pdf (365 kb)

Chairman´s report at the Annual General Meeting 2012 (Printversion)
Report of the Chairman of the Executive Board Karl-Ludwig Kleypdf (512 kb)
Documents
01.Agenda incl. proposal for the appropriation of net retained profitpdf (318 kb)
02.Control and profit and loss transfer agreement between Merck KGaA, Darmstadt, Germany, and Heipha Dr. Müller GmbH dated January 30, 2012 (Agenda item 8) (German language)pdf (1.1 MB)
03.Report of the Executive Board on the control and profit and loss transfer agreement (Agenda item 8) (German language)pdf (2.1 MB)
04.Annual Report of Merck KGaA, Darmstadt, Germany, for the fiscal year 2011 incl. the consolidated financial statements, group management report and report of the Supervisory Boardpdf (7.5 MB)
05.Single entity financial statements of Merck KGaA, Darmstadt, Germany, for the fiscal year 2011 incl. management report and report of the Supervisory Boardpdf (3.8 MB)
06.Single entity financial statements of Merck KGaA, Darmstadt, Germany, for the fiscal year 2010 incl. management report and report of the Supervisory Boardpdf (2.5 MB)
07.Single entity financial statements of Merck KGaA, Darmstadt, Germany, for the fiscal year 2009 incl. management report and report of the Supervisory Board (German language)pdf (2.1 MB)
08.Annual financial statements of Heipha Dr. Müller GmbH incl. management report for the fiscal year 2011 (German language)pdf (3.3 MB)
09.Annual financial statements of Heipha Dr. Müller GmbH incl. management report for the fiscal year 2010 (German language)pdf (14.4 MB)
10.Annual financial statements of Heipha Dr. Müller GmbH incl. management report for the fiscal year 2009 (German language)pdf (12.8 MB)
Additional Information
Explanation on shareholder rights (German language)pdf (302 kb)
Information on participation – Exercise of proxy voting

pdf (290 kb)

Information on one-time payments to the members of the Executive Board in 2011pdf (319 kb)
Voting Results 2011
Presence and voting results (German language)pdf (339 kb)
Chairman´s report at the Annual General Meeting 2011 (Printversion)
Report of the Chairman of the Executive Board Dr. Karl-Ludwig Kleypdf (274 kb)
Documents
01.Agenda incl. proposal for the appropriation of net retained profitpdf (289 kb)
02.Annual Report of Merck KGaA, Darmstadt, Germany, for fiscal 2010 incl. the consolidated financial statements, Group management report and report of the Supervisory Boardpdf (7.7 MB)
03.Single entity financial statements of Merck KGaA, Darmstadt, Germany, for fiscal 2010 incl. management report and report of the Supervisory Boardpdf (2.5 MB)
Additional Information
Explanations on shareholder rights (German language)pdf (323 kb)
Dividend Notification
Dividend for the year 2010 (German language)pdf (306 kb)
Voting Results
Presence and voting results (German language)pdf (2.5 MB)
Chairman´s report at the Annual General Meeting 2010 (Printversion)
Report of the Chairman of the Executive Board Dr. Karl-Ludwig Kleypdf (639 kb)
Documents
01.Agenda incl. proposal for the appropriation of net retained profitpdf (883 kb)
02.Annual Report of Merck KGaA, Darmstadt, Germany, for fiscal 2009 incl. the consolidated financial statements, Group management report and report of the Supervisory Boardpdf (4.3 MB)
03.Single entity financial statements of Merck KGaA, Darmstadt, Germany, for fiscal 2009 incl. management report and report of the Supervisory Board (German language)pdf (2.1 MB)
Additional Information
Information on participation and proxy votingpdf (313 kb)
Explanations on sharehoder rights (German language)pdf (1002 kb)
Dividend Notification
Dividend for the year 2009 (German language)pdf (309 kb)
Voting Results
Presence and voting results (in German only)pdf (300 kb)
Chairman´s report at the Annual General Meeting 2009 (Printversion)
Report of the Chairman of the Executive Board Dr. Karl-Ludwig Kleypdf (2.0 MB)
Documents
01.Agenda incl. proposal for the appropriation of net retained profitpdf (340 kb)
02.Control and profit and loss transfer agreement between Merck KGaA, Darmstadt, Germany, and Litec-LLL GmbH dated January 26, 2009 (German language)

pdf (361 kb)

03.Report of the Executive Board on the control and profit and loss transfer agreement (Agenda item 7)pdf (319 kb)
04.Annual Report of Merck KGaA, Darmstadt, Germany, for fiscal 2008 incl. the consolidated financial statements, Group management report and report of the Supervisory Boardpdf (1.9 MB)
05.Single entity financial statements of Merck KGaA, Darmstadt, Germany, for fiscal 2008 incl. management report and report of the Supervisory Board (German language)pdf (2.2 MB)
06.Single entity financial statements of Merck KGaA, Darmstadt, Germany, for fiscal 2007 incl. management report and report of the Supervisory Board (German language)pdf (510 kb)
07.Single entity financial statements of Merck KGaA, Darmstadt, Germany, for fiscal 2006 incl. management report and report of the Supervisory Board (German language)pdf (624 kb)
08.Annual financial statements of Litec-LLL GmbH incl. management report for 2007 (German language)pdf (304 kb)
09.Annual financial statements of Litec-LLL GmbH incl. management report for 2006 (German language)pdf (301 kb)
10.Annual financial statements of Litec-LLL GmbH incl. management report for 2005 (German language)pdf (302 kb)
11.Report of the Executive Board on the authorization to exclude subscription rights (Agenda item 11)pdf (328 kb)
Dividend Notification
Dividend for the year 2008 (German language)pdf (293 kb)
 
top

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in biopharma, “MilliporeSigma” in life science and “EMD Performance Materials” in materials business. The other company, Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.   To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone.  Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.
 
RSS FEEDS
Open the following links in a RSS Reader of your choice